MedTrace Logo

Comparing Radical Surgery and Radical Radiotherapy as First Definitive Treatment for Primary MCC

NCT05253144 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 64

Last updated 2024-05-08

No results posted yet for this study

Summary

A randomised phase III multi-centre trial comparing radical surgery and radical radiotherapy as first definitive treatment for primary MCC

Conditions

Interventions

RADIATION

Radiotherapy

Radiotherapy

PROCEDURE

Surgery

Surgery

Sponsors & Collaborators

  • Efficacy and Mechanism Evaluation (EME) Programme

    collaborator OTHER

  • University of Birmingham

    lead OTHER

Principal Investigators

  • Neil Steven · University of Birmingham

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-03-19
Primary Completion
2022-01-22
Completion
2023-04-13

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05253144 on ClinicalTrials.gov